Hauch O, Khattar S C, Jørgensen L N
Department of Surgical Gastroenterology, Copenhagen County Hospital, Gentofte, Denmark.
Semin Thromb Hemost. 1991;17 Suppl 3:280-3.
A cost-benefit analysis was performed based on the incidence of postoperative thromboembolic complications, the cost of prophylaxis, and the cost of treating the complications. It was determined that prophylaxis against thromboembolic complications in both general surgery and total hip replacement, with either standard heparin or low molecular weight heparin, saves lives as well as reduces health care costs.
基于术后血栓栓塞并发症的发生率、预防成本和并发症治疗成本进行了成本效益分析。结果表明，在普通外科手术和全髋关节置换手术中，使用标准肝素或低分子量肝素预防血栓栓塞并发症，既能挽救生命，又能降低医疗成本。
